SCHEMBL7356358

SCHEMBL7356358

O=CCCCCCN1CCNCC1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 2/20 0.55
SIGMAR1 Q99720 2/20 0.41
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GNAO1 P09471 5/20 0.39
GNAI3 P08754 4/20 0.39
GNAI1 P63096 4/20 0.39
HRH3 Q9Y5N1 1/20 0.38
TSHR P16473 1/20 0.37
LMNA P02545 1/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
RAB9A P51151 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2657753 0.98 CXCR4 (0.52) CXCR4SIGMAR1POLBSMN1; SMN2GNAO1
SCHEMBL947587 0.92 CXCR4 (0.50) CXCR4SIGMAR1POLBSMN1; SMN2HRH3
SCHEMBL986238 0.85 HRH3 (0.46) GNAO1GNAI3GNAI1HRH3TSHR
SCHEMBL984275 0.85 HRH3 (0.46) GNAO1GNAI3GNAI1HRH3TSHR
SCHEMBL999934 0.83 SMN1; SMN2 (0.45) CXCR4SIGMAR1POLBSMN1; SMN2TSHR
SCHEMBL11726023 0.82 CXCR4 (0.74) CXCR4SIGMAR1POLBSMN1; SMN2GNAO1
SCHEMBL21569302 0.82 CXCR4 (0.74) CXCR4SIGMAR1POLBSMN1; SMN2GNAO1
SCHEMBL11721752 0.82 CXCR4 (0.74) CXCR4SIGMAR1POLBSMN1; SMN2GNAO1
Hydrochloric Acid SCHEMBL8822105 0.81 SMN1; SMN2 (0.43) CXCR4SIGMAR1POLBSMN1; SMN2LMNA
Hydrochloric Acid SCHEMBL8822030 0.81 SMN1; SMN2 (0.43) CXCR4SIGMAR1POLBSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7700306-B2 characterising a polypeptide by matrix assisted laser desorption ionization (MALDI) mass spectrometry; improving sensitivity, and can increase the number of peptides that are detected from a protein ELECTROPHORETICS LIMITED (GB) 2010-04-20 US disclosed
US-5652247-A VASOPRESSIN ANTAGONIST OTSUKA PHARMACEUTICAL CO., LTD (JP) 1997-07-29 US disclosed
US-5436254-A Vaopressin antagonists OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) 1995-07-25 US disclosed
EP-0602209-A1 OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-06-22 EP disclosed
EP-0382185-B1 Carbostyril derivatives OTSUKA PHARMA CO LTD (JP) 1994-06-15 EP disclosed
WO-1994001113-A1 OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1994-01-20 WO disclosed